Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Zeldox deemed nonapprovable by the FDA

June 24, 1998

Duract withdrawn from the U.S. market due to reports of hepatotoxicity

June 24, 1998

Aspirin improves MS-related fatigue

June 24, 1998

Anseculin continues in phase II after successful testing in older volunteers

June 24, 1998

Clozapine therapy results in increased leptin levels

June 23, 1998

Integra LifeSciences to begin phase II clinical trials for Peripheral Nerve Regeneration Conduit

June 23, 1998

ABT-594, a potent analgesic with improved safety in preclinical models

June 22, 1998

Improved safety and pharmacokinetics of diazepam when administered as Diastat

June 22, 1998

New antipsychotic agents discovered at Warner-Lambert

June 22, 1998

Neurogen discovers CRF1 receptor ligands for treating stress-related disorders

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...